Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: Mayo Clin Proc. 2018 Aug 20;93(10):1375–1396. doi: 10.1016/j.mayocp.2018.03.014

Table 1.

Baseline characteristics and changes in cardiovascular related variables

Study Authors Population Mean age (yrs)/Sex/n Intervention Training Program Duration (months); Dose (mins/week) Location (Country)
Andersen et al. 201026 46.7/ M/ 13 Soccer 3; 120 Denmark
47.8/ M/ 9 Control - Denmark
Andersen et al. 2014 – A25 45.8/ M/ 20 Soccer 6; 120 Denmark
46.9/ M/ 11 Control - Denmark
Andersen et al. 2014 – B31 50.6/ M/ 10 Soccer 6; 120 Denmark
48.7/ M/ 8 Control - Denmark
Andersen et al. 2014 – C33 68/ M/ 9 Soccer 4; 120 Denmark
69.1/ M/ 9 Strength Training 4; 120 Denmark
67.4/ M/ 8 Control - Denmark
Andersen et al. 201634 68/ M/ 9 Soccer 12; 120–180 Denmark
69.1/ M/ 9 Resistance Training 12; 120–180 Denmark
67.4/ M/ 8 Control - Denmark
Bangsbo et al. 201076 37/ M/ 21 Soccer 4; 120 Denmark
37/ M/ 18 Running 4; 120 Denmark
33/M/ 12 Control - Denmark
Barene et al. 2014 – A35 44.1/ F/ 37 Soccer 3;120–180 Norway
45.9/ F/ 35 Zumba 3;120–180 Norway
47.4/ F/ 35 Control - Norway
Barene et al. 2014 – B36 44.1/ F/37 Soccer 10; 60–120 Norway
45.9/ F/ 35 Zumba 10; 60–120 Norway
47.4/ F/ 35 Control - Norway
Connolly et al. 201437 39/ F/ 13 Soccer 4; 30 -
40/ F/ 17 Vibration Training 4; 30 -
40/ F/ 14 Control - -
de Sousa et al. 201432 61/ F-9 M-10 Soccer + Dietary Counseling 3; 120 Brazil
61/ F-10 M-5 Dietary Counseling 3; 120 Brazil
Filliau et al. 201477 44.4/ F-10 M-10 Rugby 3; 90 France
Knoepfli-Lenzin et al. 201027 37/ M/ 15 Soccer 3; 180 Switzerland
36/M/ 15 Running 3; 180 Switzerland
38/ M/ 17 Control - Switzerland
Krustrup et al. 200972 30/ M/ 12 Soccer 3; 180 Denmark
31/ M/10 Running 3; 180 Denmark
30/ M/ 10 Control - Denmark
Krustrup et al. 2010 – A39 40/ F/ 7 Soccer 16;120 Denmark
40/ F/ 8 Running 16;120 Denmark
38/ F/ 7 Control - Denmark
Krustrup et al. 2010 – B78 37/ F/21 Soccer 4; 120 Denmark
37/ F/ 17 Running 4; 120 Denmark
33/ F/ 14 Control - Denmark
Krustrup et al. 201328 46/ M/ 22 Soccer 6; 120 Denmark
47/ M/ 11 Control - Denmark
Milancovic et al. 201541 -/ M/ 20 Soccer 3; 180 Serbia
-/ M/ 21 Running 3; 180 Serbia
-/ M/ 23 Control - Serbia
Mendham et al. 201540 46.8/ M/ 10 Rugby 2; 180 Australia
49.5/ M/ 11 Cycling 2; 180 Australia
49.2/ M/ 11 Control - Australia
Mohr et al. 201429 45/ F/ 21 Soccer 3.75; 180 -
43/ F/ 20 Control - -
Randers et al. 201079 31/ M/10 Soccer 16;120 Denmark
32/ M/ 7 Control - Denmark
Randers et al. 201224 37/ M/ 22 Soccer 3; 180 Denmark
43/ M/ 10 Control - Denmark
Schmidt et al. 201330 50.6/ M/ 10 Soccer 6; 120 Denmark
48.7/ M/ 8 Control - Denmark
Schmidt et al. 201442 68/ M/ 9 Soccer 12;120–180 Denmark
69.1/ M/ 9 Resistance Training 12; 120–180 Denmark
67.4/ M/ 8 Control - Denmark
Abbreviations: yrs-years
- Denotes that data was not reported, not applicable, or insufficient to carry out analyses.
Some studies included an additional intervention arm of an alternative exercise; these were not included in any pooled effect estimates.
Study Authors Weight (kg) BMI (kg/m2) WC (cm) Body Fat (%) LDL (mmol/L) HDL (mmol/L)
Andersen et al. 201026 −1.4 (4.3) 0.1 (1.1) 0 (0.4)
- - - −0.1 (6.2) 0.6 (0.9) 0.1 (0.3)
Andersen et al. 2014 – A25 - - - - - -
- - - - - -
Andersen et al. 2014 – B31 −1.1 (13.4) −0.3 (3.2) - −1.5 (3.6) - -
0.5 (18) 0.3 (6.5) - −0.2 (10.8) - -
Andersen et al. 2014 – C33 −1.1 (9.3) −0.4 (3.6) - −1.1 (7.2) −0.2 (0.8) 0.1 (0.3)
−0.3 (11.8) −0.1 (2.9) - −1.5 (6.6) −0.1 (0.6) 0.1 (0.3)
−0.5 (12.1) −0.2 (4.4) - −0.2 (5.1) −0.2 (0.6) 0 (0.3)
Andersen et al. 201634 −2.3 (9.3) −0.8 (3.5) - −1.6 (7.1) 0 (0.9) 0.2 (0.3)
−0.2 (12) −0.1 (2.9) - −1.2 (6.9) 0.2 (0.6) 0.3 (0.5)
1 (12) 0.3 (4.5) - 0.4 (4.8) 0.1 (0.7) 0 (0.3)
Bangsbo et al. 201076 - - - - - -
- - - - - -
- - - - - -
Barene et al. 2014 – A35 2 (0.3) - - 2.2 (0.4) - -
1.9 (0.3) - - 2.3 (0.4) - -
- - - - - -
Barene et al. 2014 – B36 −1.1 (3.5) - - −1.2 (2.8) −0.1 (0.8) 0 (0.3)
−2.1 (3.7) - - −1.3 (2.9) −0.2 (0.9) 0 (0.3)
- - - - - -
Connolly et al. 201437 −0.6 (2.7) - - −1.7 (2.4) - -
0.2 (2.1) - - 0.4 (1.8) - -
0 (2.1) - - −0.2 (2) - -
de Sousa et al. 201432 3.7 (0.6) −1.4 (4.4) −5.4 (0.9) 2.4 (0.4) −0.4 (0.2) 0 (0.4)
4.7 (0.7) −1.8 (4.3) −6.2 (0.4) 2.4 (0.4) 0.3 (1.2) 0 (0.4)
Filliau et al. 201477 0 (10.6) - - 0 (7.4) - -
Knoepfli-Lenzin et al. 201027 −1.6 (1.8) - −3.3 (8) −2 (4.3) −0.1 (1) 0.1 (0.4)
−1.5 (2.1) - −1.3 (8.1) −1.4 (4.2) 0 (0.8) 0 (0.4)
−0.2 (13.4) - −0.4 (10.6) 0.1 (7.2) −0.1 (0.9) 0.1 (0.4)
Krustrup et al. 200972 −1.1 (9.7) −0.3 (2.8) - −2.9 (7.6) −0.4 (0.6) 0.1 (0.3)
−1 (17) −0.3 (4.6) - −1.7 (5.2) −0.1 (0.8) 0.1 (0.3)
0 (11.8) 0 (3.5) - −0.2 (8.7) 0 (0.6) 0 (0.3)
Krustrup et al. 2010 - A39 −0.5 (8.3) −0.3 (3.3) - −1.7 (4.9) - -
−1.5 (7.5) −0.7 (2.6) - −1.9 (7.2) - -
−0.5 (11) −0.2 (3.9) - −0.8 (6.9) - -
Krustrup et al. 2010 - B78 0.3 (10.5) 0.2 (4.1) - −2 (5.7) −0.2 (0.8) 0.1 (0.5)
0.2 (7.4) −1 (3.4) - −1.7 (6.8) 0 (0.8) 0.1 (0.4)
−0.7 (9) −0.2 (3.2) - −0.8 (6.2) 0.1 (0.7) 0.1 (0.4)
Krustrup et al. 201328 - - - −2.2 (21.5) −0.3 (0.8) −0.1 (0.4)
- - - −1 (21.1) 0.3 (0.9) 0.1 (0.3)
Milancovic et al. 201541 −5.8 (8.3) −1.9 (2.2) - −4.7 (3) - -
−5.7 (5.4) −1.8 (1.9) - −4.4 (2.9) - -
2.6 (12.3) 0.8 (3) - −1.6 (4) - -
Mendham et al. 201540 −0.2 (13.5) 0 (2.9) −2.8 (7.1) −1(3.1) - 0 (0.3)
−0.5 (12.4) −0.2 (3.9) −1.3 (8.9) −0.8 (6.2) - 0 (0.3)
0.2 (11) −0.1 (3.2) −0.6 (8.6) 1 (7) - 0 (0.5)
Mohr et al. 201429 −1.4 (0.5) - - −2.1 (3.2) - -
1 (1.4) - - −0.5 (1.8) - -
Randers et al. 201079 −1.5 (7.1) - - −3.8 (8.1) −0.2 (0.6) 0.1 (0.3)
0.7 (18.2) - - −0.6 (12.7) 0.2 (1) 0 (0.5)
Randers et al. 201224 −0.7 (16.6) −0.3 (3.8) - −1.9 (8.6) −0.4 (0.6) 0 (0.4)
0.6 (16.1) 0.2 (4.2) - 0.1 (8) −0.1 (0.8) −0.1 (0.1)
Schmidt et al. 201330 −1.1 (14.7) −0.4 (3.4) - - −0.3 (0.9) 0.1 (0.3)
0.5 (19.1) 0.3 (7) - - 0.2 (1) 0.1 (0.3)
Schmidt et al. 201442 - - - - - -
- - - - - -
- - - - - -
Abbreviations: BMI- Body mass index, WC- waist circumference, LDL- low density lipoprotein, HDL:-high density lipoprotein
Study Authors Total Cholesterol (mmol/L) Triglycerides (mmol/L) SBP (mm Hg) DBP (mm Hg) RHR (beats/min) VO2 Max (mL/min/kg)
Andersen et al. 201026 0 (1.1) −0.2 (0.7) −12 (10.8) −7 (3.6) −12 (7.2) 2.5 (5.3)
0.5 (1.1) −0.3 (1.2) −5 (7.9) −3 (6) 1 (9) −1.1 (5.7)
Andersen et al. 2014 – A25 - - - - −8 (12.5) 8 (12.2)
- - - - −3 (4.5) 2 (11.6)
Andersen et al. 2014 – B31 - - - - - 3.6 (9.9)
- - - - - 0.2 (7.1)
Andersen et al. 2014 – C33 −0.1 (1.1) 0.1 (0.3) - - - 3.8 (6)
−0.3 (0.8) 0.1 (0.3) - - - 0.8 (4.9)
−0.3 (0.7) 0.1 (0.5) - - - −0.7 (5.9)
Andersen et al. 201634 −0.5 (0.9) 0 (0.3) - - - -
−0.5 (0.6) 0.1 (0.5) - - - -
−0.1 (0.8) 0.2 (0.7) - - - -
Bangsbo et al. 201076 - - - - - 5 (5)
- - - - - 3.6 (5.7)
- - - - - -
Barene et al. 2014 – A35 - - 10.7 (1.8) 7.8 (1.3) - 3.9 (0.6)
- - 10.6 (1.8) 7.5 (1.3) - 3.8 (0.6)
- - - - - -
Barene et al. 2014 – B36 0 (0.9) 0 (0.6) −0.3 (11.6) 0.8 (8.2) - 1.1 (4)
−0.2 (0.9) 0.1 (0.9) −2.1 (11.5) 0.6 (8) - 2.2 (3.9)
- - - - - -
Connolly et al. 201437 - - 2 (14.1) 1 (10.5) −4 (8) -
- - −3 (15.4) −1 (10.1) −2 (11) -
- - 1 (16.5) 0 (10.5) −3 (7.9) -
de Sousa et al. 201432 −0.6 (0.9) −0.4 (0.4) - - - -
0.4 (1.2) 0.1 (1) - - - -
Filliau et al. 201477 - - −19 (20.4) −7.5 (12) −4.8 (10.4) 2.3 (6.6)
Knoepfli-Lenzin et al. 201027 −0.3 (1.1) - - −9 (5) −7 (10.6) 4 (4.5)
−0.1 (0.9) - - −4 (6) −9 (6.2) 5.5 (5)
−0.2 (1.1) - - - −6 (8) 0.4 (5.7)
Krustrup et al. 200972 −0.2 (0.7) - −8 (6.9) −5 (6.9) −6 (6) 5 (4.7)
−0.3 (1.1) - −8 (11.4) −2 (8.4) −6 (6.3) 2.9 (7.1)
0 (0.8) - −2 (8.4) 2 (9.5) 1 (9.5) −0.3 (8.1)
Krustrup et al. 2010 – A39 - - −3 (11.5) −3 (12.1) −7 (7) 4.8 (4.4)
- - −6 (10.2) 0 (8.5) −7 (7.5) 4.5 (6.9)
- - −6 (9.5) −4 (7.9) −1 (10.6) 0.5 (4.9)
Krustrup et al. 2010 – B78 −0.1 (0.8) −0.1 (0.5) −7 (9.2) −4 (9.2) −5 (4.6) -
−0.1 (0.7) 0.1 (0.2) −7 (8.2) −3 (8.2) −6 (8.2) -
0.2 (0.7) 0.1 (0.6) −2 (7.5) −2 (7.5) 0 (7.5) -
Krustrup et al. 201328 - - −13 (9) 8 (6) −8 (11) 2.8 (2.9)
- - - - −3 (9) −0.8 (1.8)
Milancovic et al. 201541 - - - - - -
- - - - - -
- - - - - -
Mendham et al. 201540 −0.2 (1) 0.1 (0.7) - - - 4.2 (2.7)
−0.2 (0.8) 0 (0.6) - - - 3.9 (3.8)
0 (0.9) 0.2 (0.6) - - - −0.8 (5.3)
Mohr et al. 201429 −0.4 (0.5) −0.2 (0.5) −12 (13.7) −6 (9.2) −7 (9.2) -
0.1 (0.9) 0.3 (0.9) −1 (4.5) 1 (8.9) −3 (8.9) -
Randers et al. 201079 0 (0.6) −0.2 (0.7) −8 (6.3) −3 (6.3) −8 (8.4) 3.1 (3.6)
0.1 (1) −0.4 (1.4) −2 (7.3) 3 (7.9) 3 (7) −0.9 (8.7)
Randers et al. 201224 −0.1 (1.3) 0.1 (0.6) 0 (11.5) −2 (9) 4 (9.5) 3.9 (3.5)
0.1 (1.2) 0.1 (0.8) 3 (14.8) 1 (9.2) 3 (13.5) −0.3 (1.9)
Schmidt et al. 201330 −0.2 (0.9) 0.3 (0.7) −9 (15.5) −8 (7) −6 (8.7) 3.6 (3.1)
0.3 (1.2) 0.3 (0.7) 3 (16.4) 0 (9.8) 2 (19) 0.5 (7.8)
Schmidt et al. 201442 - - - - −8 (9.2) -
- - - - −2 (4.4) -
- - - - −2 (5.3) -
Abbreviations: TG-triglycerides, SBP-systolic blood pressure, DBP-diastolic blood pressure
Study Authors Fasting Blood Glucose (mmol/L) Fasting Insulin (umol/L) HbAlc (%) HOMA-IR
Andersen et al. 201026
- - - -
Andersen et al. 2014 – A25 - - - -
- - - -
Andersen et al. 2014 – B31 −1 (2.1) −6.7 (27.1) −0.4 (0.9) −0.9 (1.7)
0.9 (2.3) −1.3 (22.4) 0 (1.1) 0.8 (1.7)
Andersen et al. 2014 – C33 0.1 (0.5) −7 (13.1) 0.1 (0.3) −0.3 (0.5)
−0.1 (0.5) −6 (15.9) 0 (0.3) −0.3 (0.8)
0.1 (0.6) −8 (25.1) 0.1 (0.3) −0.3 (1.2)
Andersen et al. 201634 0 (0.5) −9 (13.1) 0 (0.3) −0.4 (0.5)
0.1 (0.5) −5 (16.7) 0 (0.3) −0.2 (0.8)
0.2 (0.5) 0 (33.3) 0 (0.3) 0 (1.6)
Bangsbo et al. 201076 - - -
- - - -
- - - -
Barene et al. 2014 – A35 - - - -
- - - -
- - - -
Barene et al. 2014 – B36 0.1 (0.8) - - -
−0.2 (1.4) - - -
- - - -
Connolly et al. 201437 - - - -
- - - -
- - - -
de Sousa et al. 201432 −0.4 (0.4) −2.2 (7.3) −1 (1.2) −1.7 (2.7)
−0.4 (0.8) −0.8 (8.3) −0.8 (1) −1.2 (3.1)
Filliau et al. 201477 - - - -
Knoepfli-Lenzin et al. 201027 - - - -
- - - -
- - - -
Krustrup et al. 200972 - - - -
- - - -
- - - -
Krustrup et al. 2010 - A39 - - - -
- - - -
- - - -
Krustrup et al. 2010 - B78 0 (0.8) 2.2 (20.8) - -
−0.4 (0.8) 2 (11.8) - -
0.1 (0.7) 11.9 (17.6) - -
Krustrup et al. 201328 0 (0.8) −4 (37.2) - -
−0.3 (0.9) 19 (58.9) - -
Milancovic et al. 201541 - - - -
- - - -
- - - -
Mendham et al. 201540 −0.3 (0.6) −15.3 (41.6) −0.3 (0.4) −0.6 (1.5)
−0.1 (0.7) −4.9 (44.1) −0.3 (0.6) −0.1 (1.9)
0 (0.9) 9 (52.7) 0 (0.4) 0.3 (2)
Mohr et al. 201429 - - - -
- - - -
Randers et al. 201079 −0.2 (0.5) - - -
0 (0.6) - - -
Randers et al. 201224 0.1 (0.6) 5 (25.2) - -
−0.2 (0.6) 11 (30.3) - -
Schmidt et al. 201330 - - −0.4 (1.2) -
- - 0 (1.2) -
Schmidt et al. 201442 - - - -
- - - -
- - - -
Abbreviations: Hba1c-hemoglobin A1c, HOMA-IR-homeostatic model assessment for insulin resistance